substance p has been researched along with Disease Exacerbation in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (10.87) | 18.2507 |
| 2000's | 19 (41.30) | 29.6817 |
| 2010's | 17 (36.96) | 24.3611 |
| 2020's | 5 (10.87) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Y; Liu, C; Ma, Y; Tang, Y; Xi, G; Xu, Y; Zhang, J | 1 |
| Alaei, A; Ebrahimi, S; Hashemy, SI; Javid, H | 1 |
| Afshari, AR; Hashemy, SI; Javid, H; Mashkani, B; Mohammadi, F | 1 |
| Fu, G; Hua, Z; Li, J; Wu, Q; Xie, D; Xu, Y; Yang, Y | 1 |
| Guan, M; Wang, Y; Ying, S | 1 |
| Carranza, A; Coveñas, R; Muñoz, M; Rosso, M | 1 |
| Amagase, K; Kato, S; Matsumoto, K; Tominaga, M; Tsukahara, T; Utsumi, D | 1 |
| Granstein, RD; Mehta, D | 1 |
| Almendro, V; Ametller, E; Costamagna, D; Engel, P; Fernandez, PL; Fernandez-Nogueira, P; Fuster, G; Garcia-Recio, S; Gascón, P; Gonzalez-Farre, X; Mancino, M; Mayordomo, C; Park, SY; Pastor-Arroyo, EM; Russnes, HG | 1 |
| Coveñas, R; Muñoz, M | 1 |
| Groffik, A; Hawro, T; Krull, C; Maurer, M; Metz, M; Saluja, R; Stanger, C; Staubach, P | 1 |
| Gupta, K; Gupta, P; Li, Y; Luk, K; Nguyen, J; Robiner, S; Saavedra, R; Soto, W; Vang, D; Vincent, L | 1 |
| Hong, HS; Son, Y | 1 |
| Ahmad, FJ; Mehboob, R; Perveen, S; Tanvir, I; Warraich, RA; Yasmeen, S | 1 |
| Cai, GQ; Chen, XD; He, JY; Li, D; Li, Z; Shen, C; Wang, H; Zhang, X; Zheng, XF; Zhu, JF | 1 |
| Cassinello, F; del Olmo, M; Prieto, I; Rivas, S; Strichartz, GR | 1 |
| Jeon, SJ; Jung, Y; Kim, JE; Kim, SH; Kim, SJ | 1 |
| Cheng, J; Kang, S; Ma, J; Yuan, S; Zhang, J; Zhao, W | 1 |
| Castro, D; Esteban, F; Gonzalez-Moles, MA; Martin-Jaen, Mdel M; Muñoz, M; Redondo, M; Ruiz-Avila, I | 1 |
| Yang, DH | 1 |
| Amin, M; Amin, S; Barbe, MF; Barr, AE; Fedorczyk, JM; Gao, HG; Litvin, J; Rani, S | 1 |
| Abe, H; Cho, H; Kubota, Y; Kurumi, Y; Tani, T; Umeda, T | 1 |
| Erin, N; Eyigor, H; Eyigor, M; Gultekin, M; Osma, U; Yilmaz, MD | 1 |
| Girard, BM; May, V; Parsons, RL; Tompkins, JD; Vizzard, MA | 1 |
| Boudah, A; Jasmin, L; Ohara, PT | 1 |
| Miśkowiak, B; Nowicki, M | 1 |
| Calhoun, K; Cheek, J; Pommier, R; Toth-Fejel, S | 1 |
| Leserman, J | 1 |
| Arai, H; Ebihara, S; Kanda, A; Nakajoh, M; Saito, H; Sasaki, H; Takahashi, H | 1 |
| Díaz, NL; Quiñones, AG; Ruiz, MR; Tapia, FJ | 1 |
| Esteban, F; González-Moles, MA; Muñoz, M; Rosso, M | 1 |
| Feakins, RM; Langmead, L; Macey, MG; Mawdsley, JE; Rampton, DS | 1 |
| Konwerska, A; Miskowiak, B; Nowicki, M; Ostalska-Nowicka, D | 1 |
| Benraiss, A; Chmielnicki, E; Cho, SR; Economides, A; Goldman, SA; Samdani, A | 1 |
| Messina, P; Ruggeri, A; Scardina, GA | 1 |
| Albino, AP; Khare, VK; Reed, JA | 1 |
| Göttinger, W; Irschick, E; Kieselbach, G; Kremser, B; Troger, J | 1 |
| Barrett, M; Bunker, CB; Mallon, E; Rosenberger, P; Rowe, A; Walsh, J | 1 |
| Binder, W; Scott, C; Walker, JS | 1 |
| Di Giulio, AM; Germani, E; Gorio, A; Lesma, E | 1 |
| Bigioni, M; Irrissuto, C; Maggi, CA; Manzini, S; Nardelli, F; Palma, C | 1 |
| Chang, FY; Chu, CJ; Hwang, SJ; Lee, FY; Lee, SD; Li, CP; Lin, HC; Lu, RH | 1 |
| Maggi, CA; Palma, C | 1 |
| Boissonade, FM; Rodd, HD | 2 |
| Iijima, T; Kabashima, H; Maeda, K; Nagata, K | 1 |
8 review(s) available for substance p and Disease Exacerbation
| Article | Year |
|---|---|
New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Topics: Breast Neoplasms; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Phosphorylation; Receptors, Neurokinin-1; Signal Transduction; Substance P | 2020 |
Immunoregulatory Effects of Neuropeptides on Endothelial Cells: Relevance to Dermatological Disorders.
Topics: Calcitonin Gene-Related Peptide; Cells, Cultured; Dermatitis, Atopic; Disease Progression; Endothelial Cells; Humans; Inflammation Mediators; Melanocyte-Stimulating Hormones; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Risk Assessment; Sensitivity and Specificity; Somatostatin; Substance P | 2019 |
Cancer progression and substance P.
Topics: Animals; Disease Progression; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P | 2014 |
Cancer surgery: how may anesthesia influence outcome?
Topics: Anesthesia; Anesthetics, Local; Apoptosis; Cell Movement; Cell Proliferation; Disease Progression; Humans; Neoplasms; Substance P; Voltage-Gated Sodium Channels | 2015 |
HIV disease progression: depression, stress, and possible mechanisms.
Topics: Catecholamines; Depression; Disease Progression; Glucocorticoids; HIV Infections; Humans; Stress, Psychological; Substance P | 2003 |
A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Disease Progression; DNA Damage; Growth Substances; Humans; Neoplasms; Neurokinin-1 Receptor Antagonists; Oncogenes; Receptors, Neurokinin-1; Signal Transduction; Substance P; Tachykinins | 2006 |
[Neurologic inflammation and oral disease. An aetiopathogenic hypothesis].
Topics: Animals; Disease Models, Animal; Disease Progression; Humans; Microcirculation; Mouth Diseases; Mouth Mucosa; Neurogenic Inflammation; Neuropeptides; Nociceptors; Pain; Rats; Substance P; Swine; Tongue; Vasoactive Intestinal Peptide | 2007 |
The role of tachykinins via NK1 receptors in progression of human gliomas.
Topics: Animals; Brain Neoplasms; Disease Progression; Glioma; Humans; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P | 2000 |
1 trial(s) available for substance p and Disease Exacerbation
| Article | Year |
|---|---|
[Effect of ear point combined therapy on plasma substance P in patients of no-aura migraine at different stages].
Topics: Acupuncture Points; Acupuncture, Ear; Adult; Disease Progression; Female; Humans; Male; Middle Aged; Migraine without Aura; Substance P; Young Adult | 2009 |
37 other study(ies) available for substance p and Disease Exacerbation
| Article | Year |
|---|---|
Bioinformatic Analysis and Cellular Assays Identify Substance P Influencing Th17/Treg Differentiation via the MyD88 Pathway as a Potential Contributor to the Progression of Asthma and Allergic Rhinitis.
Topics: Asthma; Biomarkers; Blotting, Western; Cell Line; Cytokines; Disease Progression; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-17; Myeloid Differentiation Factor 88; Real-Time Polymerase Chain Reaction; Rhinitis, Allergic; RNA, Messenger; Signal Transduction; Substance P; T-Lymphocytes, Regulatory; Up-Regulation | 2022 |
Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Topics: Apoptosis; Aprepitant; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Signal Transduction; Substance P; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Sensory denervation increases potential of bisphosphonates to induce osteonecrosis via disproportionate expression of calcitonin gene-related peptide and substance P.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Calcitonin Gene-Related Peptide; Denervation; Diphosphonates; Disease Progression; Male; Mandibular Nerve; Mice; Osteoclasts; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Substance P | 2021 |
Increased expression of transient receptor potential channels and neurogenic factors associates with cough severity in a guinea pig model.
Topics: Animals; Bleomycin; Cough; Disease Models, Animal; Disease Progression; Guinea Pigs; Idiopathic Pulmonary Fibrosis; Lung; Male; Neurogenic Inflammation; Substance P; TRPA1 Cation Channel; TRPV Cation Channels | 2021 |
Increased nuclear localization of substance P in human gastric tumor cells.
Topics: Adult; Aged; Aged, 80 and over; Cell Nucleus; Disease Progression; Female; Humans; Immunohistochemistry; Male; Middle Aged; Protein Transport; Stomach Neoplasms; Substance P | 2017 |
Transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 contribute to the progression of colonic inflammation in dextran sulfate sodium-induced colitis in mice: Links to calcitonin gene-related peptide and substance P.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Colitis; Dextran Sulfate; Disease Models, Animal; Disease Progression; Male; Mice, Inbred C57BL; Nerve Fibers; Pain; Substance P; TRPA1 Cation Channel; TRPV Cation Channels; Up-Regulation | 2018 |
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.
Topics: Apoptosis; Autocrine Communication; Blotting, Western; Breast Neoplasms; Cell Proliferation; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurotransmitter Agents; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptors, Neurokinin-1; RNA, Small Interfering; Signal Transduction; Substance P; Tumor Cells, Cultured | 2013 |
Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.
Topics: Anxiety; Biomarkers; Chronic Disease; Depression; Disease Progression; Germany; Humans; Quality of Life; Severity of Illness Index; Substance P; Up-Regulation; Urticaria | 2014 |
Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.
Topics: Analgesics, Opioid; Animals; Cytokines; Disease Progression; Female; Kaplan-Meier Estimate; Lymphangiogenesis; Mammary Neoplasms, Experimental; Mast Cells; Mice; Mice, Transgenic; Morphine; Neovascularization, Pathologic; Receptors, Opioid, mu; Substance P | 2014 |
Substance P ameliorates collagen II-induced arthritis in mice via suppression of the inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Progression; Humans; Immunosuppression Therapy; Interleukin-10; Interleukin-17; Macrophages; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred DBA; Substance P; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 2014 |
Role of neurotransmitter Substance P in progression of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Substance P; Young Adult | 2015 |
Increasing expression of substance P and calcitonin gene-related peptide in synovial tissue and fluid contribute to the progress of arthritis in developmental dysplasia of the hip.
Topics: Adult; Arthritis; Calcitonin Gene-Related Peptide; Disease Progression; Female; Gene Expression Regulation; Hip Dislocation, Congenital; Humans; Male; Middle Aged; Substance P; Synovial Fluid; Synovial Membrane; Young Adult | 2015 |
Therapeutic effects of neuropeptide substance P coupled with self-assembled peptide nanofibers on the progression of osteoarthritis in a rat model.
Topics: Amino Acid Sequence; Animals; Disease Models, Animal; Disease Progression; In Situ Nick-End Labeling; Molecular Sequence Data; Nanofibers; Osteoarthritis; Rats; Real-Time Polymerase Chain Reaction; Substance P; X-Ray Microtomography | 2016 |
Substance P Promotes the Progression of Endometrial Adenocarcinoma.
Topics: Adenocarcinoma; Cell Line, Tumor; Disease Progression; Endometrial Neoplasms; Enzyme Induction; Female; Humans; Matrix Metalloproteinase 9; Middle Aged; Receptors, Neurokinin-1; Signal Transduction; Substance P; Vascular Endothelial Growth Factor C | 2016 |
Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression.
Topics: Carcinoma; Disease Progression; Humans; Immunohistochemistry; Inflammation; Kaplan-Meier Estimate; Laryngeal Neoplasms; Receptors, Neurokinin-1; Retrospective Studies; Substance P | 2009 |
Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury.
Topics: Animals; Connective Tissue Growth Factor; Cumulative Trauma Disorders; Disease Progression; Female; Fibroblasts; Forelimb; Hand Strength; Immunohistochemistry; Interleukin-1beta; Macrophages; Rats; Rats, Sprague-Dawley; Substance P; Tendinopathy; Tendons; Time Factors | 2010 |
Abnormal development of intrinsic innervation in murine embryos with anorectal malformations.
Topics: Anal Canal; Animals; Digestive System Abnormalities; Disease Models, Animal; Disease Progression; Female; Immunohistochemistry; Mice; Myenteric Plexus; Pregnancy; Pregnancy, Animal; Proto-Oncogene Proteins c-kit; Substance P; Vasoactive Intestinal Peptide | 2012 |
Substance P and vasoactive intestinal peptide levels in middle ear effusions of children.
Topics: Age Factors; Biomarkers; Child; Child, Preschool; Chronic Disease; Cohort Studies; Disease Progression; Female; Humans; Male; Otitis Media with Effusion; Prognosis; Prospective Studies; Recurrence; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Substance P; Vasoactive Intestinal Peptide | 2012 |
Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.
Topics: Animals; Cyclophosphamide; Cystitis; Disease Progression; Galanin; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth; Nerve Growth Factor; Organ Specificity; Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Receptors, Vasoactive Intestinal Peptide, Type II; Receptors, Vasoactive Intestinal Polypeptide, Type I; Recombinant Fusion Proteins; Reflex, Abnormal; RNA, Messenger; Substance P; Urinary Bladder; Urination; Urothelium; Vasoactive Intestinal Peptide | 2012 |
Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception.
Topics: Analgesics, Opioid; Animals; Antibodies, Monoclonal; Behavior, Animal; Biphenyl Compounds; Central Nervous System; Denervation; Disease Models, Animal; Disease Progression; Female; Hyperalgesia; Immunohistochemistry; Immunotoxins; Injections, Intraventricular; Injections, Spinal; Lumbosacral Region; Male; Morphine; Norepinephrine; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Spinal Cord; Substance P; Time | 2003 |
Substance P--a potent risk factor in childhood lymphoblastic leukaemia.
Topics: Adolescent; Antigens, CD; B-Lymphocytes; Biotinylation; Bone Marrow Cells; Child; Child, Preschool; Disease Progression; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Leukemic; Glucocorticoids; Humans; Immunoenzyme Techniques; In Situ Hybridization; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; RNA Probes; RNA, Messenger; Substance P; T-Lymphocytes; Treatment Failure | 2003 |
Serum peptide profiles in patients with carcinoid tumors.
Topics: Biomarkers, Tumor; Calcitonin; Carcinoid Tumor; Chromogranin A; Disease Progression; Female; Gastrin-Releasing Peptide; Gastrins; Humans; Male; Neurotensin; Pancreatic Hormones; Pancreatic Polypeptide; Peptides; Predictive Value of Tests; Substance P; Vasoactive Intestinal Peptide | 2003 |
Impaired efficacy of cough in patients with Parkinson disease.
Topics: Aged; Cough; Disease Progression; Female; Humans; Middle Aged; Motor Neurons; Parkinson Disease; Peak Expiratory Flow Rate; Pneumonia, Aspiration; Reflex, Abnormal; Sensory Receptor Cells; Spirometry; Sputum; Substance P | 2003 |
Acute immobilization stress induces clinical and neuroimmunological alterations in experimental murine cutaneous leishmaniasis.
Topics: Acute Disease; Animals; Calcitonin Gene-Related Peptide; Disease Progression; Disease Susceptibility; Epidermis; Female; Immobilization; Immune Tolerance; Langerhans Cells; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Stress, Physiological; Substance P | 2003 |
The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Topics: Acute Disease; Adult; Biomarkers; Blood Flow Velocity; Colitis, Ulcerative; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Follow-Up Studies; Histamine; Humans; Interleukin-13; Interleukin-6; Intestinal Mucosa; Leukocyte Count; Male; Middle Aged; Rectum; Severity of Illness Index; Stress, Psychological; Substance P; Surveys and Questionnaires; Tumor Necrosis Factor-alpha | 2006 |
The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow.
Topics: Adolescent; B-Lymphocytes; Bone Marrow Diseases; Bone Marrow Examination; Cell Transformation, Neoplastic; Child; Child, Preschool; Disease Progression; Humans; Immunoenzyme Techniques; Immunophenotyping; In Situ Hybridization; Ki-67 Antigen; Leukemia; Leukemia, Myeloid, Acute; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Substance P | 2006 |
Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.
Topics: Adenoviridae; Animals; Brain-Derived Neurotrophic Factor; Carrier Proteins; Disease Models, Animal; Disease Progression; Enkephalins; Globus Pallidus; Huntington Disease; Mice; Mice, Transgenic; Mitosis; Neostriatum; Neurons; Regeneration; Substance P; Tubulin | 2007 |
The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions.
Topics: Disease Progression; Dysplastic Nevus Syndrome; Humans; Immunohistochemistry; Mast Cells; Melanoma; Precancerous Conditions; Retrospective Studies; Skin Neoplasms; Substance P | 1998 |
Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease.
Topics: Adult; Aqueous Humor; Cataract; Cryosurgery; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Radioimmunoassay; Retinal Detachment; Scleral Buckling; Substance P; Vitrectomy; Vitreoretinopathy, Proliferative | 1998 |
Depletion of cutaneous peptidergic innervation in HIV-associated xerosis.
Topics: Adult; Aging; Anti-HIV Agents; Calcitonin Gene-Related Peptide; Disease Progression; Female; HIV Infections; Humans; Male; Middle Aged; Nervous System Physiological Phenomena; Peptides; Protein Precursors; Skin; Skin Diseases; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1999 |
Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.
Topics: Acetamides; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Disease Progression; Dose-Response Relationship, Drug; Joints; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Pyrrolidines; Rats; Substance P; Tetrazoles | 1999 |
Progressive and selective changes in neurotrophic factor expression and substance p axonal transport induced by perinatal diabetes: protective action of antioxidant treatment.
Topics: Animals; Animals, Newborn; Antioxidants; Axonal Transport; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Progression; Embryonic and Fetal Development; Female; Gestational Age; In Situ Hybridization; Nerve Growth Factors; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Sprague-Dawley; Substance P | 1999 |
Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.
Topics: Animals; Cell Division; Cyclohexylamines; Cytokines; Disease Progression; Glioma; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Naphthalenes; Receptors, Tachykinin; Substance P; Tachykinins; Transplantation, Heterologous | 2000 |
Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.
Topics: Aged; Cholelithiasis; Disease Progression; Eating; Estradiol; Female; Gallbladder; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrates; Nitrites; Prevalence; Substance P; Testosterone; Ultrasonography | 2000 |
Substance P expression in human tooth pulp in relation to caries and pain experience.
Topics: Analysis of Variance; Child; Dental Caries; Dental Pulp; Disease Progression; Fluorescent Antibody Technique, Indirect; Gene Expression; Humans; Image Processing, Computer-Assisted; Linear Models; Molar; Nerve Fibers; Nerve Tissue Proteins; Neurons, Afferent; Neurotransmitter Agents; Nociceptors; Pulpitis; Substance P; Thiolester Hydrolases; Tooth Crown; Toothache; Ubiquitin Thiolesterase; Up-Regulation | 2000 |
Involvement of substance P, mast cells, TNF-alpha and ICAM-1 in the infiltration of inflammatory cells in human periapical granulomas.
Topics: Adult; Calcitonin Gene-Related Peptide; Case-Control Studies; Chemotaxis, Leukocyte; Disease Progression; E-Selectin; Endothelium, Vascular; Female; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Leukocytes, Mononuclear; Male; Mast Cells; Middle Aged; Neurogenic Inflammation; Periapical Granuloma; Substance P; Tumor Necrosis Factor-alpha | 2002 |
Comparative immunohistochemical analysis of the peptidergic innervation of human primary and permanent tooth pulp.
Topics: Analysis of Variance; Calcitonin Gene-Related Peptide; Child; Dental Caries; Dental Pulp; Dentition, Permanent; Disease Progression; Enkephalins; Fluorescent Antibody Technique, Indirect; Galanin; Humans; Molar; Neurogenic Inflammation; Neuropeptide Y; Neuropeptides; Somatostatin; Statistics, Nonparametric; Substance P; Tooth, Deciduous; Vasoactive Intestinal Peptide | 2002 |